PlasmaGen Biosciences Raises Rs 150 Crore in Funding from ViNS Bioproducts, Others
Healthcare startup PlasmaGen Biosciences has raised Rs 150 crore in a funding round led by ViNS Bioproducts.
Key Facts
| Detail | Value |
|---|---|
| Lead investor | ViNS Bioproducts |
| Sector | Plasmagen |
| Coverage | Startup Funding |
PlasmaGen Biosciences, a healthcare startup focused on plasma-derived therapies, has raised Rs 150 crore in its latest funding round.
Funding Details
The round was led by ViNS Bioproducts with participation from other investors. The funds will be used to expand manufacturing capabilities and product development.
Company Focus
PlasmaGen Biosciences specializes in plasma-derived therapeutics, an important segment of the healthcare industry that addresses various medical conditions.
Growth Plans
The investment will help the company scale its operations and strengthen its position in the Indian healthcare market.
Reported by Rohit Menon. Spotted an error in this story? Request a correction or email corrections@startupory.com. See our editorial policy.
Enjoyed this article?
Get weekly startup insights delivered to your inbox.
Related Articles
Weekly Funding Recap: Indian Startups Raised $506 Million Across 37 Deals (Jul 20 – Jul 24, 2026)
Indian startups closed 37 disclosed deals worth $506 million in the week to July 24, 2026, with electric mobility, travel tech and agentic AI absorbing more than two-thirds of the capital.
Ultraviolette Raises $95 Million Series E to Triple Electric Motorcycle Capacity
Bengaluru-based electric motorcycle maker Ultraviolette raised $95 million in a Series E round to expand manufacturing capacity to 180,000 units a year and accelerate European exports.
Stayflexi Raises $28 Million Series B to Automate Hotel Operations Across India
Hospitality software company Stayflexi raised $28 million in a Series B round to expand its property management and dynamic pricing platform to 20,000 independent hotels across India and Southeast Asia.